Company page
Basilea Pharmaceutica Ag
Basilea Pharmaceutica AG is a public company based in Switzerland, trading under the ticker BSLN. The company has a market capitalization of approximately 774 million Swiss francs. Basilea focuses on developing innovative therapies for infectious diseases and cancer, aiming to address unmet medical needs.
- Ticker
- BSLN:SIX
- Asset type
- Stock
- Market cap
- $774.2M
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- SIX
- Currency
- CHF